Results 91 to 100 of about 14,764,853 (302)

Association Between Estimated Glucose Disposal Rate and Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Zhejiang, China

Clinical Interventions in Aging
Xiangyu Chen, Ruying Hu, Feng Lu, Jieming ZhongDepartment of Non-Communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, People’s Republic of ChinaCorrespondence: Jieming Zhong ...
Chen X, Hu R, Lu F, Zhong J
doaj  

COVID-19: transferring learning from the pandemic response to non-communicable disease control. [PDF]

Public Health, 2021
Knight J, Day M, Lee ACK, Morling JR.
europepmc   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach, Sandra Donkervoort, Carola Hedberg‐Oldfors, Giovanni Baranello, Dimah Saade, Precilla D'Souza, Ruchee Patel, Eva Michael, A. Reghan Foley, Diana Bharucha‐Goebel, S. Jin Haugland, Meghan McAnally, Omer Abdul Hamid, Katherine Chao, Ellen F. Macnamara, Alan H. Beggs, Anna Sarkozy, Juliane Mueller, Steven A. Moore, Richard S. Finkel, Cynthia J. Tifft, Francesco Muntoni, Anders Oldfors, Carsten G. Bönnemann   +23 more
wiley   +1 more source

The United States Public Health Service Communicable Disease Center [PDF]

cdc:70534The Communicable Disease Center of the United States Public Health Service was inaugurated oficialyonJuly1,1946, for the field investigation and control of communicable diseases.

core  

A process evaluation of Ontario, Canada’s 2023–24 older-adult RSV vaccination program

Human Vaccines & Immunotherapeutics
Respiratory syncytial virus (RSV) is a major cause of respiratory illness in older adults. During the 2023–2024 respiratory season, Ontario was the first and only province in Canada to launch a publicly funded RSV vaccination program for older adults.
Reed Morrison, Janice Sarmiento, Jamie Park, Gillian Lim, Christina Renda, Michael Whelan, Allison McGeer, Tara Harris, Sarah E. Wilson   +8 more
doaj   +1 more source

Implementation status of non-communicable disease control program at primary health care level in Bangladesh: Findings from a qualitative research. [PDF]

Public Health Pract (Oxf), 2022
Islam K, Huque R, Saif-Ur-Rahman KM, Ehtesham Kabir ANM, Enayet Hussain AHM.   +4 more
europepmc   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Communicable disease control

This series of charts was originally prepared as a briefing tool for the Secretary's Consultants on Medical Research and Education, and presented at their meeting in Washington, D. C, on November 21, 1957.

core  

Associations between serum lipid profiles and the incidence of chronic obstructive pulmonary disease in the UK Biobank

Journal of Health, Population and Nutrition
Objective To investigate the relationship between serum lipid levels and the risk of Chronic obstructive pulmonary disease (COPD) in the UK Biobank. Methods We performed this prospective study in 381,938 adults without COPD from UK Biobank.
Mengxia Li, Bingqing Xu, Hao Yu, Yanan Wan, Zheng Zhu, Pengfei Luo, Jian Su, Jinyi Zhou, Xikang Fan   +8 more
doaj   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source